ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	JPRN
Last refreshed on:	17 October 2023
Main ID:	JPRN-UMIN000015019
Date of registration:	02/09/2014
Prospective Registration:	Yes
Primary sponsor:	Kansai medical university
Public title:	Initial therapy for myasthenia gravis of combined therapy for tacrolimus and IVIG
Scientific title:	Initial therapy for myasthenia gravis of combined therapy for tacrolimus and IVIG - Combined therapy for tacrolimus and IVIG
Date of first enrolment:	2014/09/02
Target sample size:	20
Recruitment status:	Recruiting
URL:	https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017472
Study type:	Interventional
Study design:	Single arm Non-randomized
Phase:	Not applicable

Countries of recruitment
Japan

Contacts

Name:	Kengo Fujita
Address:	Osaka pref. Hirakata city Japan
Telephone:	072-804-0101
Email:	fujitake@hirakata.kmu.ac.jp
Affiliation:	Kansai medical university Neurology

Name:	kengo fujita
Address:	Hirakata city Japan
Telephone:	072-804-0101
Email:	fujitake@hirakata.kmu.ac.jp
Affiliation:	kansai medical univ. neurology

Key inclusion & exclusion criteria

Inclusion criteria:
Exclusion criteria: indication for thymectomy

Age minimum: Not applicable
Age maximum: Not applicable
Gender: Male and Female

Health Condition(s) or Problem(s) studied

Myasthenia gravis

Intervention(s)

Tacrolimus and IVIG

Primary Outcome(s)

QMG score and MGFA post-intervention status

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Kansai medical university

Secondary Sponsor(s)

Ethics review

Status: YES
Approval date:
Contact:

Results

Results available:	Yes
Date Posted:
Date Completed:	31/03/2016
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.